🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#NephMadness is here!!!!! ajkdblog.org/2025/03/01/wel…

Happy #ThankAFellowWeek! We celebrated our incredible fellows with great food, sweets, laughter, and an intense game of Pictionary! We’re so grateful for each and every one of them—the future of Nephrology is bright! #NephrologyFellows #MedEd #Gratitude

𝗦𝗔𝗩𝗘 𝗧𝗛𝗘 𝗗𝗔𝗧𝗘 for the Industry Webinar: "A New Dawn for IgA Nephropathy – Redefining What is Possible With Sparsentan." 🗣️ Nasim Wiegley, MD, FASN Sydney Tang 🗓️ March 11 🕒 3 pm CET 🔗 Free registration: lite.spr.ly/60071o6f

Anticoagulant-related nephropathy by Dr. Irene Martin, Dr. Paolo Nikolai So, Dr. Tiffany Caza and Dr. Mohamed Hassanein Read here 👉 pubs.glomcon.org/anticoagulant-… #GlomCon

Our #NephMadness fun is in full swing! Our fellows have passionately debated #DisasterNephrology, #ObesityInTransplant, #MCD, & #Genetics—learning, laughing, and maybe even a little trash-talking! Can’t wait for more discussions & our epic voting party! #NephMadness2025 #MedEd

Our Division #NephMadness 2025 party was a blast! Our Nephrology superheroes brought the energy—defending their picks with enthusiasm, friendly competition, and a sprinkle of trash talk. Fun learning, lots of laughs, and of course,delicious food and cake! #MedEd #NephMadness2025

Don't forget to check out the #NephMadness PodCrawl ajkdblog.org/2025/03/01/nep…

Excited to be at #RPA2025 this weekend, presenting on #IgANephropathy. Looking forward to connecting with friends and meet new ones! RPA-Nephrology

#NephMadness 2025 Commentary by Nasim Wiegley, MD, FASN: Anti-Nephrin Antibodies – The Breakthrough That Will Transform Minimal Change Disease Management bit.ly/NM25Wiegley

#NephMadness 2025 Commentary by Zainab Obaidi: CAR-T – The First of its Name bit.ly/NM25Obaidi

The #Nephmadness2025 finale is here and it’s a glomerular showdown!! #MDC Anti-nephrin antibodies vs CAR-T — both with the power to reshape how we manage GD! Check out this Amanda Kirwan🇪🇺🇺🇦 post by our faculty Nasim Wiegley, MD, FASN. NephMadness

🌟Dr. Nasim Wiegley, MD, FASN, our fellowship PD & one of our #Glomerular Disease clinic faculty, presenting at #RPA2025 on #IgANephropathy. RPA-Nephrology Women In Nephrology UCDavisMedSchool Edgar V. Lerma 🇵🇭

IgM Variant of Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits: A Case Series bit.ly/3Ec18Od #OpenAccess Bhanu Prasad Sanjeev Sethi #VisualAbstract

C5b9uPR is emerging as a significant biomarker for FSGS progression, reflecting the complex interplay between complement activation, inflammation, and kidney injury. bit.ly/KID0787 #ASNKidney360

🚨 Exciting News! 🚨 The GlomCon Foundation, American Kidney Fund, and iganfoundation have joined forces to develop the consensus framework for establishing Centers of Excellence in Glomerular Disease Care! This collaboration will define standards for improving patient care, advancing

Sibeprenlimab Halves uPCR in IgA Nephropathy (IgAN) Trial from Vlado Perkovic Medscape #ERA25 🇦🇹 #Nephpearls medscape.com/viewarticle/si…

🎉 This weekend, we celebrated our incredible graduating Fellows as they take the next step as #Nephrologists! 🩺So proud of their hard work & can’t wait to see their amazing impact on patients & the nephrology community. Congrats Drs. Vuyyuru, Luo, Ray, & Broka!🌟 #MedTwitter

APOL1 Mediated Kidney Disease (AMKD): Clinical approach to genetic testing ca. 2025 from Kidney Medicine GlomCon Edward Kwakyi Paolo Nikolai So Nasim Wiegley, MD, FASN #Nephpearls kidneymedicinejournal.org/article/S2590-…

🎉 The celebrations continue as we welcome our new #Nephrology Fellows—the future stars of kidney care! 💫 We’re ready for an amazing and unforgettable year of learning, fun, and teamwork! #Fellowship #Nephtwitter

Age can play an important role in how nephrologists treat individuals with glomerular diseases. This #ASNCJASN "How I Treat" article highlights key insights: kidney.pub/CJASN0805